OKAYAMA UNIVERSITY

Kobe University-led research finds low-dose aspirin or heparin treatment effective in preventing pregnancy loss or complications in women with self-targeting antibodies, with 87% live births in treated group vs. 50% in untreated, and complications reduced from 50% to 6%.